214 related articles for article (PubMed ID: 23328212)
1. Cerebrospinal fluid high-mobility group box protein 1 in neuromyelitis optica and multiple sclerosis.
Wang H; Wang K; Wang C; Xu F; Zhong X; Qiu W; Hu X
Neuroimmunomodulation; 2013; 20(2):113-8. PubMed ID: 23328212
[TBL] [Abstract][Full Text] [Related]
2. CSF high-mobility group box 1 is associated with intrathecal inflammation and astrocytic damage in neuromyelitis optica.
Uzawa A; Mori M; Masuda S; Muto M; Kuwabara S
J Neurol Neurosurg Psychiatry; 2013 May; 84(5):517-22. PubMed ID: 23255728
[TBL] [Abstract][Full Text] [Related]
3. Notable increased cerebrospinal fluid levels of soluble interleukin-6 receptors in neuromyelitis optica.
Wang H; Wang K; Zhong X; Dai Y; Qiu W; Wu A; Hu X
Neuroimmunomodulation; 2012; 19(5):304-8. PubMed ID: 22777162
[TBL] [Abstract][Full Text] [Related]
4. Elevated plasma high-mobility group box 1 protein is a potential marker for neuromyelitis optica.
Wang KC; Tsai CP; Lee CL; Chen SY; Chin LT; Chen SJ
Neuroscience; 2012 Dec; 226():510-6. PubMed ID: 23122444
[TBL] [Abstract][Full Text] [Related]
5. Impaired regulatory function and enhanced intrathecal activation of B cells in neuromyelitis optica: distinct from multiple sclerosis.
Quan C; Yu H; Qiao J; Xiao B; Zhao G; Wu Z; Li Z; Lu C
Mult Scler; 2013 Mar; 19(3):289-98. PubMed ID: 22864301
[TBL] [Abstract][Full Text] [Related]
6. Increased soluble C5b-9 in CSF of neuromyelitis optica.
Wang H; Wang K; Wang C; Qiu W; Lu Z; Hu X
Scand J Immunol; 2014 Feb; 79(2):127-30. PubMed ID: 24313854
[TBL] [Abstract][Full Text] [Related]
7. Interleukin-17-secreting T cells in neuromyelitis optica and multiple sclerosis during relapse.
Wang HH; Dai YQ; Qiu W; Lu ZQ; Peng FH; Wang YG; Bao J; Li Y; Hu XQ
J Clin Neurosci; 2011 Oct; 18(10):1313-7. PubMed ID: 21795048
[TBL] [Abstract][Full Text] [Related]
8. Cerebrospinal fluid IL-21 levels in Neuromyelitis Optica and multiple sclerosis.
Wu A; Zhong X; Wang H; Xu W; Cheng C; Dai Y; Bao J; Qiu W; Lu Z; Hu X
Can J Neurol Sci; 2012 Nov; 39(6):813-20. PubMed ID: 23041403
[TBL] [Abstract][Full Text] [Related]
9. Cerebrospinal fluid levels of CXCL13 are elevated in neuromyelitis optica.
Zhong X; Wang H; Dai Y; Wu A; Bao J; Xu W; Cheng C; Lu Z; Qiu W; Hu X
J Neuroimmunol; 2011 Dec; 240-241():104-8. PubMed ID: 22036953
[TBL] [Abstract][Full Text] [Related]
10. Cerebrospinal fluid α-synuclein levels are elevated in multiple sclerosis and neuromyelitis optica patients during replase.
Wang H; Wang K; Xu W; Wang C; Qiu W; Zhong X; Dai Y; Wu A; Hu X
J Neurochem; 2012 Jul; 122(1):19-23. PubMed ID: 22469018
[TBL] [Abstract][Full Text] [Related]
11. The HMGB1 is increased in CSF of patients with an Anti-NMDAR encephalitis.
Ai P; Zhang X; Xie Z; Liu G; Liu X; Pan S; Wang H
Acta Neurol Scand; 2018 Feb; 137(2):277-282. PubMed ID: 29023630
[TBL] [Abstract][Full Text] [Related]
12. Urinary trypsin inhibitor levels are reduced in cerebrospinal fluid of multiple sclerosis and neuromyelitis optica patients during relapse.
Shu Y; Li R; Yang Y; Dai Y; Qiu W; Chen Y; Zhao Z; Lu Z; Hu X
Neurochem Int; 2015 Feb; 81():28-31. PubMed ID: 25555815
[TBL] [Abstract][Full Text] [Related]
13. Analyses of haptoglobin level in the cerebrospinal fluid and serum of patients with neuromyelitis optica and multiple sclerosis.
Chang KH; Tseng MY; Ro LS; Lyu RK; Tai YH; Chang HS; Wu YR; Huang CC; Hsu WC; Kuo HC; Chu CC; Chen CM
Clin Chim Acta; 2013 Feb; 417():26-30. PubMed ID: 23262373
[TBL] [Abstract][Full Text] [Related]
14. Cerebrospinal fluid light and heavy neurofilaments in neuromyelitis optica.
Wang H; Wang C; Qiu W; Lu Z; Hu X; Wang K
Neurochem Int; 2013 Dec; 63(8):805-8. PubMed ID: 24161620
[TBL] [Abstract][Full Text] [Related]
15. Cerebrospinal fluid levels of iodothyronines and nerve growth factor in patients with multiple sclerosis and neuromyelitis optica.
Jiang Y; Yang Y; Zhang B; Peng F; Bao J; Hu X
Neuro Endocrinol Lett; 2009 Mar; 30(1):85-90. PubMed ID: 19300400
[TBL] [Abstract][Full Text] [Related]
16. Increased levels of CSF CD59 in neuromyelitis optica and multiple sclerosis.
Uzawa A; Mori M; Uchida T; Masuda H; Ohtani R; Kuwabara S
Clin Chim Acta; 2016 Jan; 453():131-3. PubMed ID: 26686775
[TBL] [Abstract][Full Text] [Related]
17. Markedly increased CSF interleukin-6 levels in neuromyelitis optica, but not in multiple sclerosis.
Uzawa A; Mori M; Ito M; Uchida T; Hayakawa S; Masuda S; Kuwabara S
J Neurol; 2009 Dec; 256(12):2082-4. PubMed ID: 19655191
[TBL] [Abstract][Full Text] [Related]
18. Distinguishing the cerebrospinal fluid cytokine profile in neuropsychiatric systemic lupus erythematosus from other autoimmune neurological diseases.
Ichinose K; Arima K; Ushigusa T; Nishino A; Nakashima Y; Suzuki T; Horai Y; Nakajima H; Kawashiri SY; Iwamoto N; Tamai M; Nakamura H; Origuchi T; Motomura M; Kawakami A
Clin Immunol; 2015 Apr; 157(2):114-20. PubMed ID: 25656641
[TBL] [Abstract][Full Text] [Related]
19. Increased interleukin-6 correlates with myelin oligodendrocyte glycoprotein antibodies in pediatric monophasic demyelinating diseases and multiple sclerosis.
Horellou P; Wang M; Keo V; Chrétien P; Serguera C; Waters P; Deiva K
J Neuroimmunol; 2015 Dec; 289():1-7. PubMed ID: 26616865
[TBL] [Abstract][Full Text] [Related]
20. Characteristic cerebrospinal fluid cytokine/chemokine profiles in neuromyelitis optica, relapsing remitting or primary progressive multiple sclerosis.
Matsushita T; Tateishi T; Isobe N; Yonekawa T; Yamasaki R; Matsuse D; Murai H; Kira J
PLoS One; 2013; 8(4):e61835. PubMed ID: 23637915
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
